Reducing Tobacco Harm: Finding the Best Route for Africa

Aug.15.2022
Reducing Tobacco Harm: Finding the Best Route for Africa
Reducing tobacco harm is a public health strategy that advocates for harm reduction products as a practical approach to lower smoking rates.

The entire world agrees that smoking rates need to be decreased. Whether it's the ubiquitous cigarette or local cigars and hookahs known as shisha in Nigeria, all stakeholders want to reduce smoking rates, and in fact, keep reducing them. While cigarettes have always received the most attention, people are now beginning to recognize the dangers of shisha, especially as it becomes increasingly popular among young people.


However, the means to achieve the expected decrease in smoking rates continue to cause debate among various parties. The popular African saying, "there are different paths to reach the same destination" is a subtle way our ancestors chose to remind us that the destination is the ultimate goal. Naturally, as long as the expected destination or established objective is reached, everything is fair and great, without any mistakes made along the way.


In fact, this motto has never been more important than in the process of reducing smoking rates in Africa today. While the debate about the path to this destination continues, prohibitionists – those who believe that only complete abstinence from smoking can achieve a decrease in smoking rates – continue to denigrate advocates for harm reduction, while also denying the success of harm reduction plans.


The photo, taken by Haim Charbit on Unsplash, represents a public health strategy called tobacco harm reduction (THR), which aims to reduce personal and wider societal health risks associated with combustible tobacco products. This approach is based on the understanding that most of the harm related to combustible tobacco is caused by the chemical mixture released when tobacco is burned (smoked) and then inhaled. However, if you remove the smoking/burning element, the risk of consuming tobacco is significantly reduced.


THR advocates believe that many adult smokers who wish to quit smoking often struggle or cannot quit, while others wish to continue to enjoy nicotine without harmful effects. Therefore, these smokers should switch to alternative products that release nicotine without burning tobacco. The word "switching" is an effective term for THR advocates, who prioritize the freedom to switch and the availability of alternative options. Providing information on alternative or reduced-risk products is a key driver of effective THR strategies for adult consumers to make informed choices.


Recently, advocates of tobacco harm reduction (THR) have been promoting their cause in Africa by explaining the science behind the concept and citing successful records from countries that have accepted the ideology of reducing tobacco harm. It is worth noting that THR advocates still agree that quitting smoking is the best choice and frequently emphasize this fact. However, they have chosen a pragmatic approach because they understand that both quitting smoking and switching will achieve the goal of reducing smoking rates. The position of THR advocates is supported by scientific evidence from more developed economies, which recognizes that adopting and effectively implementing tobacco harm reduction strategies can significantly reduce smoking rates. For example, the United Kingdom has recognized the effectiveness of reducing tobacco harm or substituting tobacco products in lowering smoking rates. The National Institute for Health and Care Excellence (NICE), which publishes evidence-based guidelines for the most effective methods of disease prevention, diagnosis, and treatment, has also released guidelines for tobacco harm reduction. The guidelines acknowledge that quitting smoking is always the best choice for smokers, but they support the use of licensed nicotine-containing products (NCPs) to help smokers who are currently unable to quit transition to less harmful options.


The Food and Drug Administration (FDA) of the United States of America (USA) has begun to classify alternative products as "reduced-risk tobacco products". This is a clear indication that the country is relying on scientific and verified evidence to provide guidance on reducing tobacco harm.


According to reports, Japan's smoking rate has decreased by 34% primarily due to the introduction of alternative products that give citizens the opportunity to switch to lower-risk options rather than outright quitting. This was detailed in a report by renowned consultancy firm Frost & Sullivan in December 2020, which also emphasized the importance of establishing effective regulation.


In Canada, the government has released a scientifically-supported statement through the Canadian Ministry of Health, stating that "completely replacing smoking with e-cigarettes will reduce your exposure to harmful chemicals" and "e-cigarette products and e-cigarettes release nicotine in a smaller way than smoking." Others are advising adult smokers to stay away from combustible tobacco products. The Canadian Public Health Association also recognizes the efficacy of alternative products and has released statements since 2018 acknowledging that the risks associated with alternative nicotine delivery products are lower than combustible tobacco.


New Zealand's Ministry of Health launched a website called Vaping Facts in 2019 with the aim of educating citizens about the realities of using e-cigarettes as a smoking cessation tool. The website encourages smokers to consider e-cigarettes as a means of quitting smoking and widely disseminates content indicating that the risks associated with vaping are lower than with smoking. This is another clear example of a country using a scientific and fact-based approach to reduce the harm caused by tobacco.


African countries need to conduct independent evaluations of each potential pathway towards reducing smoking rates. Their health departments and other health organizations, including academic members, must commission independent research focused not only on reducing tobacco harm but also examining the numerous public health issues affecting their citizens. This will aid in determining the best policies and regulatory frameworks to effectively promote smoking cessation and reduce tobacco harm simultaneously.


Statement


This article is compiled from third-party information and is intended for industry professionals for communication and learning purposes.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the content. The translation of this article is only for industry exchange and research purposes.


Due to limitations in the skill level of the translator, the translation may not accurately reflect the original text. Please refer to the original text for accuracy.


2FIRSTS maintains complete alignment with the Chinese government's positions and statements regarding domestic issues, as well as those concerning Hong Kong, Macau, Taiwan, and international relationships.


The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

FDA and NIH Release New Wave 8 Restricted-Use PATH Study Data Files
FDA and NIH Release New Wave 8 Restricted-Use PATH Study Data Files
FDA’s Center for Tobacco Products and NIH’s National Institute on Drug Abuse announced that new Wave 8 restricted-use data files from the PATH Study are now available. The files contain data collected between January 2024 and December 2024, including questionnaire data, location characteristics data, and state identifier data.
Apr.17 by 2FIRSTS.ai
FDA Says It Will Not Take Enforcement Action Against Zone Nicotine Pouches Until Lawsuit Is Resolved
FDA Says It Will Not Take Enforcement Action Against Zone Nicotine Pouches Until Lawsuit Is Resolved
The U.S. Food and Drug Administration has told vape manufacturer Fontem US that it does not presently intend to take enforcement action against the company’s Zone nicotine pouches while litigation over the agency’s handling of the application remains unresolved.
Apr.07 by 2FIRSTS.ai
Argentina Issues Resolution 549/2026 to Regulate Vapes, Heated Tobacco and Nicotine Pouches
Argentina Issues Resolution 549/2026 to Regulate Vapes, Heated Tobacco and Nicotine Pouches
Argentina’s government has created a comprehensive regulatory framework for nicotine products, including vapes, heated tobacco and nicotine pouches, through Resolution 549/2026 published in the Official Gazette. The new regulation ends the previous prohibitive framework and establishes rules to organize the market by requiring traceability, quality standards and mandatory registration for all manufacturers and retailers operating in the country.
May.06 by 2FIRSTS.ai
Seoul to Fine Use of Liquid E-Cigarettes in No-Smoking Areas From April 24
Seoul to Fine Use of Liquid E-Cigarettes in No-Smoking Areas From April 24
Seoul will begin fining the use of all tobacco products, including liquid e-cigarettes, in no-smoking areas from April 24, when the revised Tobacco Business Act takes effect.
Apr.09 by 2FIRSTS.ai
ZYN by IQOS to Roll Out Across Tokyo From May 11 Through IQOS Shops and Lawson
ZYN by IQOS to Roll Out Across Tokyo From May 11 Through IQOS Shops and Lawson
Philip Morris Japan announced on April 23 at a product briefing that ZYN by IQOS, an oral tobacco pouch previously launched in selected areas, will expand sales in Tokyo. The company said the product will be released progressively from May 11 through IQOS shops, Lawson and other outlets in the city. The launch will include four flavors, each offered in Low and Medium intensity levels, for a total of eight products.
Apr.27 by 2FIRSTS.ai
 RFK Jr. Spokesman Resigns Over FDA Authorization of Fruit-Flavored Vapes
RFK Jr. Spokesman Resigns Over FDA Authorization of Fruit-Flavored Vapes
Richard Danker, a senior public affairs official in Health Secretary Robert F. Kennedy Jr.’s team, resigned from his role at HHS over the FDA’s recent authorization of fruit-flavored vaping products. In a resignation letter addressed to President Donald Trump, Danker argued that the products could expose minors to nicotine addiction, lung damage, and increased cancer risks, while also conflicting with recent HHS guidance on youth risks associated with flavored nicotine products.
News
May.15